The WHO Technical Advisory Group reviewed candidate vaccines for Bundibugyo virus disease (BVD) and provided recommendations on prioritization for future development and clinical evaluation
Année de publication
2026
ebola-BDBV
Cette ressource apparaît sur le Thème suivant:
Cette ressource est incluse dans le tableau suivant:
| Titre | Auteur | Année | Type | Langue |
|---|
| WHO Technical Advisory Group on candidate vaccine prioritization (TAG-CVP) for BVD candidate vaccine prioritization (TAG-CVP) meeting report, 31 July 2026 | World Health Organization (WHO) | 2026 | Report | Anglais |
| Frequently asked questions (FAQs) on Bundibugyo Virus Disease vaccines and therapeutics | World Health Organization (WHO), WHO Regional Office for Africa (AFRO) | 2026 | Datasheet | Anglais, Français |
| GNN webinar: Updates on existing and pipeline Ebola vaccines | Helen Rees, Reena Doshi, Alejandro Costa, Melanie Marti, Pierre Gsell | 2026 | Webinar | Anglais |
| WHO emergency guidance on the use of licensed Ebola vaccine during Bundibugyo virus disease outbreaks: interim guidance, 31 August 2026 | World Health Organization (WHO) | 2026 | Guidance | Anglais, Français |
| WHO emergency guidance on the use of licensed Ebola virus vaccine during Bundibugyo virus disease outbreaks, 28 May 2026 | World Health Organization (WHO) | 2026 | Guidance | Anglais |
| WHO target product profile for Bundibugyo virus disease vaccines | World Health Organization (WHO) | 2026 | Report | Anglais |
| WHO Technical Advisory Group on Candidate Vaccine Prioritization Meeting report, 19 and 25 May 2026 | World Health Organization (WHO) | 2026 | Report | Anglais |
Ajouté par: Reena Doshi
Ajouté le: 2026-06-09 09:54:39
Consultations: 704
